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BACKGROUND It has not been examined whether high Lp(a) levels are able to predict
long-term adverse cardiovascular outcomes in patients (pts) undergoing percuta-
neous coronary intervention (PCI) with drug-eluting stents (DESs). The aim of this
study is to assess the impact of Lp(a) levels on the major clinical outcomes following
PCI with DESs.
METHODS A total of 674 consecutive pts with angina pectoris who underwent elec-
tive PCI with DESs from 2004 to 2009 were enrolled. The pts were divided into two
groups according to the levels of Lp(a): Low Lp(a) group [Lp(a)<50 mg/dL, n¼559],
and High Lp(a) group [Lp(a)50 mg/dL, n¼115]. The clinical outcomes were compared
between the two groups.
RESULTS The incidence of any myocardial infarction (MI), revascularization, target
lesion revascularization (TLR), target vessel revascularization (TVR), All-major
adverse cardiac events (MACEs), and stent thrombosis was higher in the High Lp(a)
group as compared to Low Lp(a) group. However, the incidence of total death and
cardiac death were similar between the two groups. In multivariate logistic regression
analysis adjusted by gender, age, diabetes mellitus, hypertension, hyperlipidemia,
smoking, multivessel disease, LDL-cholesterol, Lp(a)50 mg/dL was signiﬁcantly
associated with the 5-year adverse clinical outcomes including any MI, revasculari-
zation, TLR, TVR, and All-MACEs.
CONCLUSIONS In our study, angina pectoris pts with high Lp(a) level50 mg/dL
undergoing elective PCI with DESs in Asian population was signiﬁcantly associated
with adverse clinical outcomes at 5 years.Table. Five year clinical outcome qccording to Lp(a) groupsRESTENOSIS
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BACKGROUND Drug coated balloons have been developed to address some of the
shortcomings of stents as implantable prostheses in peripheral vascular intervention.
The biological proﬁle and efﬁcacy of DCB are strongly related to the formulation of
the coating. This study conducted pharmacokinetic, safety and efﬁcacy studies to
characterize the paclitaxel (PTX) balloon coating of the Eurocor FREEWAY DCB.
METHODS AND RESULTS Forty-two domestic swine underwent percutaneous
FREEWAY overstretch balloon dilation for 1 and 2minutes of both femoral and iliac (4-5
and 6-8 mm diameter, respectively) arteries. Tissue paclitaxel concentrations and the
vascular functionweremeasured at 1h, 1, 3 and 9days. Neointimal hyperplasia (NH)was
quantiﬁed by computerized planimetry 5 weeks post-DCB use in a (DCB vs. non-coated
control balloon) pre-clinical study. The peripheral artery tissue drug levels were
141.937.9 vs. 566.3179.9, 43.213.6 vs. 149.471.8, 23.48.4 vs. 30.016.6 and3.22.4 vs. 4.01.1 ng/mg using 1 vs. 2 minutes balloon inﬂation time at 1h, 1, 3 and 9
days post-DCBuse, respectively. TheNHwas signiﬁcantly smaller in the arteries dilated
with FREEWAY comparedwith control balloon. DCB led to impairment of endothelium-
dependent vasodilation in a tissue PTX dose-dependent manner.
CONCLUSIONS In a pre-clinical porcine model, PTX tissue concentration from the
FREEWAY DCB is directly related to time of balloon inﬂation. DCB reduced the NH in
peripheral arteries compared to uncoated balloons. Vascular function impairment
was directly related to tissue PTX concentration.ANGIOMYOGENESIS, CELL THERAPY, GENE THERAPY
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INTRODUCTION Intravenous delivery of MSCs for MI could have major clinical im-
plications. Also, MSCs grown under chronic hypoxic conditions have attributes sug-
gesting more robust healing and homing functions. Therefore, we studied whether
human and murine hypoxic MSCs trafﬁc to the heart following myocardial injury and
preferentially home to regions of ischemia.
METHODS CD1 male control mice and mice that underwent LAD ligation surgery
with 45 minutes of ischemia followed by reperfusion (I/R) received tail-vein injection
24 hours following surgery with either 10e6 indium-111 radiolabeled hypoxic murine
or human MSCs grown at 5% O2 (n¼10 in each group). Organs were harvested 24
hours post-injection, gamma well counting was performed, and hearts were
sectioned and phosphor-imaging was performed to assess signal intensity in the LAD
region vs the non-ischemic territory. TTC staining was performed to assess for
infarction.
RESULTS For both human and murine MSCs, phosphor-imaging demonstrated pref-
erential homing of radiolabeled MSCs to the LAD region vs. non-ischemic region of
the LV following IR while there is no difference in control mice (Figure with phosphor
image and corresponding TTC staining below). Following radiolabeled MSC injection,
signal intensity was signiﬁcantly increased in the LAD region vs. posterior wall
following IR compared with control mice (343% vs 31%, p<0.0001). Gamma well
counting demonstrated an increase in the number of MSCs to the hearts following IR
vs control hearts (3425  264 MSCs/gm vs 1975  160 MSCs/gm, p¼0.0002). The
number of MSCs per heart signiﬁcantly correlated with the size of MI by TTC staining
(Spearman R 0.61, p¼0.004).
CONCLUSIONS Following amurinemodel ofMI, radiolabeled hypoxic human andmurine
MSCs trafﬁc to the heart and preferentially home to regions of myocardial injury.
